Context Therapeutics Inc. Common Stock (CNTX) Technical Analysis
$0.60▲7.14%
Market is closed - opens 7 PM, 29 Jun 2026
Insights
- Context Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Context Therapeutics Inc. stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Context Therapeutics Inc. stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Context Therapeutics Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 18.68 | Buy |
Stochastic | 0.99, 1.65 | Neutral |
Ultimate Oscillator | 22.36 | Buy |
Stochastic Relative Strength Index | 9.3, 7.91 | Buy |
Moving Average Convergence Divergence | -0.49, -0.41 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.78 | Sell |
20 | 1.46 | Sell |
50 | 2.01 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.84 | Sell |
20 | 1.25 | Sell |
50 | 1.81 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.74 | Sell |
20 | 0.91 | Sell |
50 | 1.36 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.42 | Sell |
20 | 0.63 | Sell |
50 | 1.31 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.42 | Buy |
20 | 0.36 | Sell |
50 | 0.9 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.73 |
Resistance L2 | 0.7 |
Resistance L1 | 0.64 |
Pivot Point | 0.61 |
Support L1 | 0.54 |
Support L2 | 0.51 |
Support L3 | 0.45 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.